Announcement of the Resolution of the 10th Meeting of the 4th Board of Directors

release time:

2025-04-24 14:02

AnnouncementNumber: 2025-003

Stock code: 832316                          Securities abbreviation: Tian Zheng Biotech                       Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd

Announcement of the Resolution of the 10th Meeting of the 4th Board of Directors

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint legal responsibility for the authenticity, accuracy and completeness of its content.

 

I. Meeting Convening and Attendance
(1) Meeting convening situation
The meeting will be held on April 22, 2025
2. Meeting venue: Conference Room on the third floor of the company
3. Meeting format: It will be held on-site
4. Time and method for issuing the notice of the board meeting: It will be issued in writing on April 12, 2025
5. Chairperson of the meeting: Mr. CAI Tiyuan, Chairman of the Board
6. Attendees of the meeting: Li Xiaoting, Song Yao, Wang Yanping
7. Explanation of the legality and compliance of the convening situation:
The convening and holding of this meeting comply with the relevant provisions of the Company Law and other laws, administrative regulations and the Company's Articles of Association.
(II) Attendance at the meeting
Five directors were supposed to attend the meeting, and five directors attended or were authorized to attend.

 

Ii. Review of the Motion
(1) The proposal on the "2024 Annual General Manager's Work Report of the Company" was reviewed and approved
1. Content of the motion:
"General Manager's Work Report for 2024"
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion does not need to be submitted to the shareholders' meeting for deliberation.
(2) The proposal on the "2024 Board of Directors' Work Report of the Company" was reviewed and approved
1. Content of the motion:
"2024 Board of Directors' Work Report"
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(3) The proposal on the Company's "2024 Financial Settlement Report" was reviewed and approved
1. Content of the motion:
"2024 Financial Settlement Report"
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(4) The proposal on the Company's "2025 Financial Budget Plan" was reviewed and approved
1. Content of the motion:
"Financial Budget Plan for 2025"
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(V) The proposal on the Company's "2024 Annual Report and Abstract of the 2024 Annual Report" was reviewed and approved
1. Content of the motion:
"Annual Report 2024 and Summary of the Annual Report 2024"
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.

(6) The proposal on the Company's "Profit Distribution Plan for 2024" was reviewed and approved
1. Content of the motion:
In order to enhance the financial stability, strengthen the ability to resist risks, achieve the company's sustained, stable and healthy development, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, after research and decision by the board of directors: no profit distribution for the year 2024 will be made.
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(7) The proposal on the re-appointment of Zhongxi Certified Public Accountants (Special General Partnership) as the company's auditing institution for 2025 was deliberated and approved
1. Content of the motion:
The company intends to continue to employ Zhongxi Certified Public Accountants (Special General Partnership) as the auditing institution for the year 2025, with a term of one year.
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion still needs to be submitted to the shareholders' meeting for deliberation.
(8) The proposal on convening the 2024 Annual General Meeting of shareholders was deliberated and approved
1. Content of the motion:
It is requested that the company hold the 2024 Annual General Meeting of Shareholders in the company's meeting room on May 12, 2025, to review the matters submitted for deliberation at this general meeting of shareholders.
2. Voting result of the motion: 5 votes in favor; 0 votes against; There were 0 abstentions.
3. Avoidance of voting:
None.
4. Submit the voting situation of the shareholders' meeting:
This motion does not need to be submitted to the shareholders' meeting for deliberation.
 

 

Iii. Directory of Reference Documents
Resolution of the 10th Meeting of the 4th Board of Directors of Jilin Tianzheng Biotechnology Co., LTD.
"Confirmation Opinions of Directors, Supervisors and Senior Management on the 2024 Annual Report"
 

 

Jilin Tianzheng Biotechnology Co., LTD
Board of Directors
April 22, 2025